Wang HL, Chou AH, Wu AS, Chen SY, Weng YH, Kao YC, et al
It's best to follow a healthcare provider's advice
Here's what you should know going in: Commonly reported effects include nausea, vomiting, diarrhea, and constipation, particularly during initial dose escalation Warnings and precautions in the prescribing information for applicable semaglutide and tirzepatide products cover pancreatitis, gallbladder disease, and kidney injury associated with volume depletion If you're on insulin or sulfonylureas, discuss hypoglycemia risk with your prescriber - GLP-1 medications can affect blood sugar control when combined with those drugs These medications slow gastric emptying, which can affect how orally taken medications are absorbed - worth flagging if you take other oral drugs regularly Certain FDA-approved semaglutide and tirzepatide products carry a boxed warning concerning thyroid C-cell tumors observed in rodents
PT-141 (bremelanotide) is a metabolite of Melanotan II and was developed specifically for its effects on sexual function without significant pigmentation activity
Is burping from semaglutide a sign the medication isn't working
